Prognostic significance of preoperative bowel obstruction in stage III colorectal cancer

Annals of Surgical Oncology

Volumn 18, Issue 9, 2011, Pages 2432-2441

  Katoh, Hiroshi ^a   Yamashita, Keishi ^a   Wang, Guoqin ^a   Sato, Takeo ^a   Nakamura, Takatoshi ^a   Watanabe, Masahiko ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; ADVANCED CANCER; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; COLORECTAL CANCER; DISEASE FREE SURVIVAL; FEMALE; HIGH RISK PATIENT; HUMAN; INTESTINE OBSTRUCTION; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PROGNOSIS; TUMOR DIFFERENTIATION;

COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTESTINAL OBSTRUCTION; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREOPERATIVE PERIOD; PROGNOSIS; SURVIVAL RATE;

EID: 80052747333     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1625-3     Document Type: Article

References (39)

1. YB Cho SH Yun JS Hong, et al. 2008 Carcinoma obstruction of the left colon and long-term prognosis Hepatogastroenterology. 55 1288 1292 18795674
2. GT Deans CC Patterson TG Parks, et al. 1994 Colorectal carcinoma: importance of clinical and pathological factors in survival Ann R Coll Surg Engl. 76 59 64 8117023 1:STN:280:DyaK2c7mtFCnsQ%3D%3D (Pubitemid 24030549)
3. JK Jiang YT Lan TC Lin, et al. 2008 Primary vs. delayed resection for obstructive left-sided colorectal cancer: impact of surgery on patient outcome Dis Colon Rectum. 51 306 311 18183462 10.1007/s10350-007-9173-4 1:STN:280:DC%2BD1c7islGksw%3D%3D
4. JS Lee 1986 Distension pressure on subserosal and mesenteric lymph pressures of rat jejunum Am J Physiol. 251 G611 G614 3777168 1:STN:280:DyaL2s%2Fks1ekug%3D%3D
5. HE Mulcahy MM Skelly A Husain DP O'Donoghue 1996 Long-term outcome following curative surgery for malignant large bowel obstruction Br J Surg. 83 46 50 8653361 10.1002/bjs.1800830114 1:STN:280:DyaK283msVSntg%3D%3D (Pubitemid 26018804)
6. U Ohman 1982 Prognosis in patients with obstructing colorectal carcinoma Am J Surg. 143 742 747 7046484 10.1016/0002-9610(82)90050-2 1:STN:280: DyaL383ivVaqsg%3D%3D (Pubitemid 12087285)
7. HC Umpleby RC Williamson 1984 Survival in acute obstructing colorectal carcinoma Dis Colon Rectum. 27 299 304 6714046 10.1007/BF02555634 1:STN:280:DyaL2c7otF2qtQ%3D%3D (Pubitemid 14138788)
8. HS Wang JK Lin CY Mou, et al. 2004 Long-term prognosis of patients with obstructing carcinoma of the right colon Am J Surg. 187 497 500 15041498 10.1016/j.amjsurg.2003.12.028 (Pubitemid 38373804)
9. CW Fitchett GC Hoffman 1986 Obstructing malignant lesions of the colon Surg Clin North Am. 66 807 820 3738701 1:STN:280:DyaL283ovFynuw%3D%3D (Pubitemid 16014079)
10. P Garcia-Peche A Vazquez-Prado R Fabra-Ramis R Trullenque-Peris 1991 Factors of prognostic value in long-term survival of colorectal cancer patients Hepatogastroenterology. 38 438 443 1765364 1:STN:280:DyaK387ht1WqsA%3D%3D
11. M Omejc Z Stor F Jelenc S Repse 1998 Outcome after emergency subtotal/total colectomy compared to elective resection in patients with left-sided colorectal carcinoma Int Surg. 83 241 244 9870783 1:STN:280:DyaK1M%2Fos1egsg%3D%3D (Pubitemid 128463247)
12. T Andre C Boni L Mounedji-Boudiaf, et al. 2004 Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Engl J Med. 350 2343 2351 15175436 10.1056/NEJMoa032709 1:CAS:528:DC%2BD2cXks1Gjt78%3D (Pubitemid 38702845)
13. JM Jessup A Stewart FL Greene BD Minsky 2005 Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation JAMA. 294 2703 2711 16333005 10.1001/jama.294.21.2703 1:CAS:528: DC%2BD2MXht12rtLnL (Pubitemid 41770099)
14. H Katoh K Yamashita T Sato, et al. 2009 Prognostic significance of peritoneal tumour cells identified at surgery for colorectal cancer Br J Surg. 96 769 777 19526618 10.1002/bjs.6622 1:STN:280:DC%2BD1MvjtFKjsw%3D%3D
15. DB Rubin 1997 Estimating causal effects from large data sets using propensity scores Ann Intern Med. 127 757 763 9382394 1:STN:280: DyaK2svmvVKitQ%3D%3D (Pubitemid 27446562)
16. G Burdy Y Panis A Alves, et al. 2001 Identifying patients with T3-T4 node-negative colon cancer at high risk of recurrence Dis Colon Rectum. 44 1682 1688 11711742 10.1007/BF02234390 1:STN:280:DC%2BD3MnmsFKgtg%3D%3D (Pubitemid 33126988)
17. P Baccari P Bisagni S Crippa, et al. 2006 Operative and long-term results after one-stage surgery for obstructing colonic cancer Hepatogastroenterology. 53 698 701 17086871 (Pubitemid 44682985)
18. B Psaila D Lyden 2009 The metastatic niche: adapting the foreign soil Nat Rev Cancer. 9 285 293 19308068 10.1038/nrc2621 1:CAS:528:DC%2BD1MXjsFSrtrk%3D
19. C Alix-Panabieres S Riethdorf K Pantel 2008 Circulating tumor cells and bone marrow micrometastasis Clin Cancer Res. 14 5013 5021 18698019 10.1158/1078-0432.CCR-07-5125 1:CAS:528:DC%2BD1cXpslKgtr4%3D
20. K Podsypanina YC Du M Jechlinger, et al. 2008 Seeding and propagation of untransformed mouse mammary cells in the lung Science. 321 1841 1844 18755941 10.1126/science.1161621 1:CAS:528:DC%2BD1cXhtFCrtLrI
21. DN Granger PR Kvietys NA Mortillaro AE Taylor 1980 Effect of luminal distension on intestinal transcapillary fluid exchange Am J Physiol. 239 G516 G523 7446745 1:STN:280:DyaL3M%2FotlGrtQ%3D%3D
22. A Mantovani 2009 Cancer: inflaming metastasis Nature. 457 36 37 19122629 10.1038/457036b 1:CAS:528:DC%2BD1MXhtVGguw%3D%3D
23. A Mantovani P Allavena A Sica F Balkwill 2008 Cancer-related inflammation Nature. 454 436 444 18650914 10.1038/nature07205 1:CAS:528:DC%2BD1cXovV2mtbg%3D
24. CA Vaccaro FA Bonadeo ML Benati, et al. 2004 Colorectal cancer staging: reappraisal of N/PN classification Dis Colon Rectum. 47 66 69 14719153 10.1007/s10350-003-0004-y (Pubitemid 38040247)
25. N Wolmark B Fisher HS Wieand 1986 The prognostic value of the modifications of the Dukes' C class of colorectal cancer. An analysis of the NSABP clinical trials Ann Surg. 203 115 122 3511864 10.1097/00000658-198602000- 00001 1:STN:280:DyaL287ivFKjsQ%3D%3D (Pubitemid 16144695)
26. PM Johnson GA Porter R Ricciardi NN Baxter 2006 Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer J Clin Oncol. 24 3570 3575 16877723 10.1200/JCO.2006.06.8866 (Pubitemid 46630528)
27. AC Berger ER Sigurdson T LeVoyer, et al. 2005 Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes J Clin Oncol. 23 8706 8712 16314630 10.1200/JCO.2005.02.8852 (Pubitemid 46211514)
28. HY Lee HJ Choi KJ Park, et al. 2007 Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma Ann Surg Oncol. 14 1712 1717 17253102 10.1245/s10434-006-9322-3 (Pubitemid 46791006)
29. P Schumacher S Dineen C Barnett Jr, et al. 2007 The metastatic lymph node ratio predicts survival in colon cancer Am J Surg. 194 827 831 18005779 10.1016/j.amjsurg.2007.08.030 (Pubitemid 350086537)
30. J Wang JM Hassett MT Dayton MN Kulaylat 2008 Lymph node ratio: role in the staging of node-positive colon cancer Ann Surg Oncol. 15 1600 1608 18327530 10.1245/s10434-007-9716-x
31. GJ Chang MA Rodriguez-Bigas JM Skibber VA Moyer 2007 Lymph node evaluation and survival after curative resection of colon cancer: systematic review J Natl Cancer Inst. 99 433 441 17374833 10.1093/jnci/djk092 (Pubitemid 47073566)
32. TE Le Voyer ER Sigurdson AL Hanlon, et al. 2003 Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089 J Clin Oncol. 21 2912 2919 12885809 10.1200/JCO.2003.05.062 1:STN:280:DC%2BD3szltlersA%3D%3D (Pubitemid 46621841)
33. H Ishida H Miwa M Tatsuta, et al. 2004 Ki-67 and CEA expression as prognostic markers in Dukes' C colorectal cancer Cancer Lett. 207 109 115 15050740 10.1016/j.canlet.2003.10.032 1:CAS:528:DC%2BD2cXisF2gsLY%3D (Pubitemid 38429893)
34. Sobin LH, Wittekond Ch, editors. International Union Against Cancer (UICC). TNM classification of malignant tumors. 6th ed. New York: Wiley; 2002.
35. GY Locker S Hamilton J Harris, et al. 2006 ASCO. 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer J Clin Oncol 24 5313 5327 17060676 10.1200/JCO.2006.08.2644 1:CAS:528: DC%2BD28XhtlemurfN (Pubitemid 46631379)
36. H Katoh K Yamashita Y Kokuba, et al. 2008 Diminishing impact of preoperative carcinoembryonic antigen (CEA) in prognosis of Dukes' C colorectal cancer Anticancer Res. 28 1933 1941 18630484 (Pubitemid 351892909)
37. G Lanza R Gafa A Santini, et al. 1998 Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study Cancer. 82 49 59 9428479 10.1002/(SICI)1097-0142(19980101) 82:1<49::AID-CNCR6>3.0.CO;2-F 1:STN:280:DyaK1c%2FovVOmtw%3D%3D (Pubitemid 28070479)
38. HJ Andreyev AR Norman D Cunningham, et al. 2001 Kirsten ras mutations in patients with colorectal cancer: the "RASCAL II" study Br J Cancer. 85 692 696 11531254 10.1054/bjoc.2001.1964 1:CAS:528:DC%2BD3MXns1yktr8%3D (Pubitemid 32929467)
39. IA Ahmed SB Kelly JJ Anderson, et al. 2008 The predictive value of p53 and p33(ING1b) in patients with Dukes' C colorectal cancer Colorectal Dis. 10 344 351 17949449 10.1111/j.1463-1318.2007.01317.x 1:STN:280: DC%2BD1c3ltVyqsQ%3D%3D (Pubitemid 351524251)